dehydroepiandrosterone has been researched along with rifampin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bay, ML; Besedovsky, H; Bongiovanni, B; Bottasso, O; Brandan, N; D'Attilio, L; Del Rey, A; Díaz, A; Dídoli, G; Fernández, RDV; Gardeñez, W; Kovalevski, L; Lioi, S; Nannini, LJ; Santucci, N | 1 |
1 review(s) available for dehydroepiandrosterone and rifampin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
2 other study(ies) available for dehydroepiandrosterone and rifampin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The clinical recovery of tuberculosis patients undergoing specific treatment is associated with changes in the immune and neuroendocrine responses.
Topics: Adult; Antitubercular Agents; C-Reactive Protein; Case-Control Studies; Dehydroepiandrosterone; Ethambutol; Female; Gene Expression Regulation; Humans; Hydrocortisone; Interferon-gamma; Interleukin-6; Isoniazid; Leukocytes, Mononuclear; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Receptors, Glucocorticoid; Rifampin; Transforming Growth Factor beta; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |